Park Medi World

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE119201023
  • NSEID: PARKHOSPS
  • BSEID: 544645
INR
245.15
5.9 (2.47%)
BSENSE

May 06

BSE+NSE Vol: 5.23 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.23 lacs (-7.63%) Volume

Shareholding (Mar 2026)

FII

0.86%

Held by 11 FIIs

DII

2.77%

Held by 13 DIIs

Promoter

82.89%

Why is Park Medi World Ltd falling/rising?

06-May-2026

As of 05-May, Park Medi World Ltd's stock price is at 239.25, showing a minor decline but strong overall performance with a year-to-date gain of 63.20%. The stock has reached a new 52-week high and is trading above its moving averages, indicating a positive trend and increased investor interest.

As of 05-May, Park Medi World Ltd's stock price is currently at 239.25, reflecting a slight decline of 0.95 (-0.4%). Despite this minor drop, the stock has shown strong performance over recent periods. Over the past week, it has increased by 2.16%, and in the last month, it has surged by 21.32, significantly outperforming the Sensex, which only rose by 5.04% in the same timeframe. Year-to-date, the stock has achieved an impressive gain of 63.20%, while the Sensex has decreased by 9.63%.<BR><BR>Today, the stock reached a new 52-week high of Rs.245.4, indicating strong upward momentum. It has outperformed its sector by 0.42% today and has experienced consecutive gains over the last two days, accumulating a total return of 4.52% during this period. Additionally, Park Medi World is trading above its moving averages across various timeframes, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a positive trend.<BR><BR>Investor participation has also increased, with a delivery volume of 4.64 lacs on May 4, marking a 22.1% rise compared to the 5-day average. This indicates growing interest and confidence among investors. Furthermore, the stock's liquidity is adequate for trading, as it represents 2% of the 5-day average traded value.<BR><BR>In summary, while there is a slight decline in the current price, the overall trend for Park Medi World Ltd remains positive, supported by strong performance metrics and increasing investor engagement.

View full answer

Which are the latest news on Park Medi World?

06-May-2026
No latest news for Park Medi World found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 10,541 Cr (Small Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

61

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.24

stock-summary
Return on Equity

18.85%

stock-summary
Price to Book

9.72

Revenue and Profits:
Net Sales:
410 Cr
(Quarterly Results - Dec 2025)
Net Profit:
51 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
59.34%
0%
59.34%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Park Medi World for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Acquisition

04-May-2026 | Source : BSE

Incorporation of Wholly owned Subsidiary

Launch Of Hospital In Panchkula

10-Apr-2026 | Source : BSE

Launch of Hospital in Panchkula

Update On Product Launch

27-Mar-2026 | Source : BSE

Update on Launch of Hospital- Panchkula

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
4.43
Debt to EBITDA (avg)
1.51
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.02
Tax Ratio
24.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.11%
ROCE (avg)
36.12%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
53
Industry P/E
61
Price to Book Value
9.90
EV to EBIT
34.54
EV to EBITDA
29.25
EV to Capital Employed
8.15
EV to Sales
7.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.59%
ROE (Latest)
18.85%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Bullish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (5.62%)

FIIs

Held by 11 FIIs (0.86%)

Promoter with highest holding

Ajit Gupta (74.59%)

Highest Public shareholder

Kotak Contra Fund (5.07%)

Individual Investors Holdings

3.96%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 40.32% vs 43.63% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 70.29% vs 4,650.00% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.87",
          "val2": "32.69",
          "chgp": "40.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.02",
          "val2": "15.29",
          "chgp": "17.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.61",
          "val2": "3.43",
          "chgp": "5.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "14.56",
          "val2": "8.55",
          "chgp": "70.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "39.28%",
          "val2": "46.77%",
          "chgp": "-7.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Park Medi World"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Park Medi World"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 2.26% vs -12.57% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -4.27% vs 5.49% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.58",
          "val2": "89.56",
          "chgp": "2.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.03",
          "val2": "25.64",
          "chgp": "-6.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.34",
          "val2": "13.65",
          "chgp": "-9.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.18",
          "val2": "7.50",
          "chgp": "-4.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.24%",
          "val2": "28.63%",
          "chgp": "-2.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
45.87
32.69
40.32%
Operating Profit (PBDIT) excl Other Income
18.02
15.29
17.85%
Interest
3.61
3.43
5.25%
Exceptional Items
0.00
0.00
Standalone Net Profit
14.56
8.55
70.29%
Operating Profit Margin (Excl OI)
39.28%
46.77%
-7.49%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 40.32% vs 43.63% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 70.29% vs 4,650.00% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
91.58
89.56
2.26%
Operating Profit (PBDIT) excl Other Income
24.03
25.64
-6.28%
Interest
12.34
13.65
-9.60%
Exceptional Items
0.00
0.00
Standalone Net Profit
7.18
7.50
-4.27%
Operating Profit Margin (Excl OI)
26.24%
28.63%
-2.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 2.26% vs -12.57% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -4.27% vs 5.49% in Mar 2024

stock-summaryCompany CV
About Park Medi World Ltd stock-summary
stock-summary
Park Medi World Ltd
Small Cap
Hospital
Park Medi World Limited was incorporated at New Delhi as `Park Medi World Private Limited' as a private limited company dated January 20, 2011, with the Registrar of Companies, Delhi and Haryana at New Delhi . Subsequently, Company converted to a public limited company and the name of the Company was changed to `Park Medi World Limited', dated December 20, 2024 through a fresh Certificate of Incorporation issued by the Central Processing Centre.
Company Coordinates stock-summary
Icon
No Company Details Available